Skip to main content

Table 3 Laboratory values in 44 HD patients on the final day of investigation (Week 5, Day 2; see Table 2); however, values for inflammatory markers, hsCRP, orosomucoid and PTX3, are shown as median values over 4 weeks plus the final day of investigation

From: Inflammation down-regulates CYP3A4-catalysed drug metabolism in hemodialysis patients

Laboratory parameters

 hsCRP, mg/L ª

4.5 (1.5–14.0)

 Interleukin-6, pg/ml

6.0 (3.0–10.6)

 Orosomucoid, g/L ª

1.0 (0.8–1.3)

 Pentraxin 3, ng/ml ª

1.3 (1.1–2.0)

 NT-pro-brain natriuretic peptide, ng/L

6330 (1285–21,830)

 Parathyroid hormone, ng/L

322 (151–587)

 Albumin, g/L

33 (32–36)

 Iron, μg/L

10 (8–13)

 4β-OH-Cholesterol, ng/ml

26 (14–26)

 Cholesterol, mmol/L

3.9 (3.4–4.7)

 Urea reduction rate, %

74 (70–78)

 Hemoglobin, g/L

115 (106–121)

  1. Data presented as median and interquartile range (IQR). ª Median values for high sensitive (hs) CRP, orosomucoid and pentraxin-3 are calculated from the five samples taken during 4 weeks prior to the study plus the last day of the study. The rest of the parameters are sampled at day 2 of week 5